Free Trial

Enliven Therapeutics (ELVN) Earnings Date, Estimates & Call Transcripts

$23.38
+1.37 (+6.22%)
(As of 04:27 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(May. 14)
-$0.54 Beat By $0.04
Consensus EPS
(May. 14)
-$0.58
Skip Charts & View Estimated and Actual Earnings Data

ELVN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELVN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Enliven Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20241($0.51)($0.51)($0.51)
Q3 20241($0.56)($0.56)($0.56)
Q4 20241($0.58)($0.58)($0.58)

ELVN Earnings Date and Information

Enliven Therapeutics last announced its quarterly earnings data on May 14th, 2024. The reported ($0.54) EPS for the quarter, beating analysts' consensus estimates of ($0.58) by $0.04. Enliven Therapeutics has generated ($1.93) earnings per share over the last year (($1.93) diluted earnings per share). Earnings for Enliven Therapeutics are expected to decrease in the coming year, from ($2.26) to ($2.74) per share. Enliven Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.

Enliven Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2024
(Estimated)
------- 
5/14/2024Q1 2024($0.58)($0.54)+$0.04($0.54)--
3/14/2024Q4 2023($0.56)($0.47)+$0.09($0.47)--
11/9/2023Q3 2023($0.49)($0.51)($0.02)($0.51)--
8/10/2023Q2 2023($0.40)($0.41)($0.01)($0.41)--
5/11/2023Q1 2023($0.67)($0.80)($0.13)($0.80)--
2/10/2023Q4 2022-$4.92+$4.92$4.92--
10/25/2022Q3 2022-($0.72)($0.72)($0.72)--
8/3/2022Q2 2022($2.24)($1.76)+$0.48($1.76)--
5/6/2022Q1 2022($2.28)($2.24)+$0.04($2.24)--
3/15/2022Q4 2021($3.16)($2.12)+$1.04($2.12)--
11/9/2021Q3 2021($3.64)($2.20)+$1.44($2.20)--
8/6/2021Q2 2021($3.08)($2.96)+$0.12($2.96)--
5/11/2021Q1 2021($3.36)($2.32)+$1.04($2.32)--
3/5/2021Q4 2020($3.36)($4.36)($1.00)($4.36)--
11/5/2020Q3 2020($3.32)($2.88)+$0.44($2.88)--
8/14/2020Q2 2020($2.44)($2.36)+$0.08($2.36)--
5/7/2020Q1 2020($2.96)($17.24)($14.28)($17.24)--

Enliven Therapeutics Earnings - Frequently Asked Questions

When is Enliven Therapeutics's earnings date?

Enliven Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on ELVN's earnings history.

Did Enliven Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Enliven Therapeutics (NASDAQ:ELVN) reported ($0.54) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.58) by $0.04. Learn more on analysts' earnings estimate vs. ELVN's actual earnings.

How much profit does Enliven Therapeutics generate each year?

Enliven Therapeutics (NASDAQ:ELVN) has a recorded net income of -$71.58 million. ELVN has generated -$1.93 earnings per share over the last four quarters.

What is Enliven Therapeutics's EPS forecast for next year?

Enliven Therapeutics's earnings are expected to decrease from ($2.26) per share to ($2.74) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ELVN) was last updated on 7/22/2024 by MarketBeat.com Staff

From Our Partners